Bayer

Project facts

Decision / announcement date

2026-10-02

Date precision

day

Sector

Life sciences & medical

Facility action

New facility

Facility type

Pharmaceutical manufacturing campus

Project status

Announced

Project / facility

New pharmaceutical manufacturing site (modular campus: drug substance module, then drug product module)

Figures & qualifications

Capital category

Committed

Capital scope

site

Jobs classification

New/Direct

Jobs basis

Bayer: 'expected to create around 600 high-value jobs' (approximate). About 1,500 construction jobs not counted.

Bayer will invest $2.2 billion in a modular pharmaceutical manufacturing campus, creating around 600 jobs. The first module is expected to operate in 2031 and the second in 2034.